I only feel comfortable suggesting an RCT of routine vaccines because I am confident it wouldn't get off the ground.
The New Normal Five years ago, COVID-19 was declared a global pandemic, marking the official onset of a healthcare crisis ...
Manually producing the TLF involves an interplay of biostatisticians, terminology coders, statistical programmers, and ...
Effective drug discovery and development hinge on high-quality data. Implementing FAIR principles enhances data usability and ...
Targeted chemotherapy in the abdomen using a technique called PIPAC combined with systemic standard-of-care chemotherapy is shown to be safe, with promising activity for patients with colorectal and a ...
VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant and clinically ...
4d
Pharmaceutical Technology on MSNAmid deglobalising trade, experts seek AI safeguards for clinical trial supplyInnovation, collaboration, and regulatory reform were on the agenda at the 2025 Clinical Trial Supply Europe conference.
Scientific literature has increased at a rate of 8-9% annually since 1980, doubling every decade and creating an information ...
IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions and clinical research services to the healthcare and life sc ...
Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.
A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at ...
Raghava's research has been broadly accepted in peer-reviewed journals, industry conferences, and regulatory discussions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results